Expanding Horizons in Melanoma Treatments Dr. Marcus Butler, MD

Marcus Butler is a medical oncologist with the Princess Margaret Cancer Centre and an Assistant Professor at the University of Toronto.
He cares for patients with melanoma and gynecologic malignancies and is the Clinical Head of the Immune Monitoring Team at Princess Margaret Cancer Centre. His work focuses on the development of immunotherapy trials, which include studies, alone and in combination, of immune checkpoint blocking antibodies, immunomodulators, and adoptive cell transfer.
Recorded live in Toronto June 6th 2019, Toronto Melanoma Information Session.
For more information on our Melanoma Information Sessions visit
www.melanomanetwork.ca/patien...
Melanoma Treatment Information www.melanomanetwork.ca/drugthe...
Melanoma Support
www.melanomanetwork.ca/support/
If you are looking for support, reach us today. We are here to support you through your journey. Contact: Mary Zawadzki B.A, SSW, RSSW
1.877.560.8035 x 108
[e-mail].

[@Alien2799]

What is the survival for stage 1 melanoma?

[@MelanomaCanada]

Please note that these are approximate as many factors come into play to assess an individuals prognosis.
stage 1A
97%
stage 1B
92%

[@Alien2799]

@@MelanomaCanada My surgeon said that it is 98.5% Why such discrepancy?